NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 132 filers reported holding NEOGENOMICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,170,000 | -10.4% | 45,000 | 0.0% | 3.27% | +635.7% |
| Q4 2020 | $2,423,000 | +46.0% | 45,000 | 0.0% | 0.44% | +67.3% |
| Q3 2020 | $1,660,000 | -10.7% | 45,000 | -25.0% | 0.27% | -1.8% |
| Q2 2020 | $1,859,000 | -55.1% | 60,000 | -60.0% | 0.27% | -56.3% |
| Q1 2020 | $4,141,000 | -5.6% | 150,000 | 0.0% | 0.62% | +84.5% |
| Q4 2019 | $4,387,000 | +32.4% | 150,000 | -13.4% | 0.34% | +100.0% |
| Q3 2019 | $3,313,000 | -25.7% | 173,277 | -14.8% | 0.17% | -7.7% |
| Q2 2019 | $4,460,000 | +3.4% | 203,277 | -3.6% | 0.18% | +26.4% |
| Q1 2019 | $4,313,000 | +62.3% | 210,807 | 0.0% | 0.14% | +58.2% |
| Q4 2018 | $2,658,000 | -37.7% | 210,807 | -24.2% | 0.09% | -17.3% |
| Q3 2018 | $4,269,000 | +17.1% | 278,132 | 0.0% | 0.11% | +29.4% |
| Q2 2018 | $3,646,000 | +60.6% | 278,132 | 0.0% | 0.08% | +80.9% |
| Q1 2018 | $2,270,000 | -7.9% | 278,132 | 0.0% | 0.05% | +2.2% |
| Q4 2017 | $2,464,000 | – | 278,132 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |